Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Ali, Omar Hasan; Bomze, David; Ring, Sandra; Berner, Fiamma; Fässler, Mirjam; Diem, Stefan; Abdou, Marie-Therese; Hammers, Christoph; Emtenani, Shirin; Braun, Anne; Cozzio, Antonio; Mani, Bernhard; Jochum, Wolfram; Schmidt, Enno; Zillikens, Detlef; Sadik, Christian D; Flatz, Lukas (2019). BP180-specific IgG is associated with skin adverse events, therapy response and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. Journal of the American Academy of Dermatology:Epub ahead of print.

Berner, Fiamma; Bomze, David; Diem, Stefan; Ali, Omar Hasan; Fässler, Mirjam; Ring, Sandra; Niederer, Rebekka; Ackermann, Christoph J; Baumgaertner, Petra; Pikor, Natalia; Cruz, Cristina Gil; van de Veen, Willem; Akdis, Mübeccel; Nikolaev, Sergey; Läubli, Heinz; Zippelius, Alfred; Hartmann, Fabienne; Cheng, Hung-Wei; Hönger, Gideon; Recher, Mike; Goldman, Jonathan; Cozzio, Antonio; Früh, Martin; Neefjes, Jacques; Driessen, Christoph; Ludewig, Burkhard; Hegazy, Ahmed N; Jochum, Wolfram; Speiser, Daniel E; Flatz, Lukas; et al (2019). Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer. JAMA Oncology, 5(7):1043.

Diem, Stefan; Fässler, Mirjam; Bomze, David; Ali, Omar Hasan; Berner, Fiamma; Niederer, Rebekka; Hillmann, Dorothea; Mangana, Joanna; Levesque, Mitchell P; Dummer, Reinhard; Risch, Lorenz; Recher, Mike; Risch, Martin; Flatz, Lukas (2019). Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. Journal of Immunotherapy, 42(3):89-93.

Fässler, Mirjam; Diem, Stefan; Mangana, Joanna; Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Ring, Sandra; Niederer, Rebekka; Del Carmen Gil Cruz, Cristina; Pérez Shibayama, Christian Ivan; Krolik, Michal; Siano, Marco; Joerger, Markus; Recher, Mike; Risch, Lorenz; Güsewell, Sabine; Risch, Martin; Speiser, Daniel E; Ludewig, Burkhard; Levesque, Mitchell P; Dummer, Reinhard; Flatz, Lukas (2019). Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. Journal for ImmunoTherapy of Cancer, 7:50.

Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Fässler, Mirjam; Diem, Stefan; Cozzio, Antonio; Jörger, Markus; Früh, Martin; Driessen, Christoph; Lenz, Tobias L; Flatz, Lukas (2019). Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. European Journal of Cancer, 107:8-14.

This list was generated on Thu Sep 19 02:17:24 2019 CEST.